Press Release   Date Link  
           
  Integrated BioPharma Reports Results for its Quarter Ended September 30, 2019   11/13/19 PDF  
           
  Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2019   09/16/19 PDF  
           
  Integrated BioPharma Reports Results for its Quarter Ended March 31, 2019 and Announces Refinancing of its Senior Credit Facility with PNC Bank, National Association   05/15/19 PDF  
           
  Integrated BioPharma Names Christina Kay and Riva Sheppard as Co-Chief Executive Officers   05/01/19 PDF  
           
  Integrated BioPharma Announces Conversion of $5,350,000 Convertible Debt to Equity   08/01/18 PDF  
           
  INTEGRATED BIOPHARMA ANNOUNCES CLOSING OF $11.7 MILLION REVOLVING CREDIT FACILITY AND REFINANCING OF SUBORDINATED DEBT   06/29/12 PDF  
           
  INTEGRATED BIOPHARMA, INC. ANNOUNCES VOLUNTARY DELISTING OF ITS COMMON STOCK   04/13/09 HTM  
           
           
  Tax Basis Information - Distribution of iBioPharma Common Stock     [click here]  
           
           
 
 
225 Long Avenue, Hillside, NJ 07205 USA
Tel 973.926.0816  Fax 973.926.1735
Investor Relations 888.319.6962